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Abstract
Background: Formaldehyde, a widely used chemical, is considered a human carcinogen. We report the results of
a meta-analyses of studies on the relationship between occupational exposure to formaldehyde and risk of non-
Hodgkin lymphoma (NHL).
Methods: We performed a systematic review and meta-analysis according to international guidelines and we
identified 12 reports of occupational populations exposed to formaldehyde. We evaluated inter-study heterogeneity
and we applied a random effects model. We conducted a cumulative meta-analysis and a meta-analysis according
to estimated average exposure of each study population.
Results: The meta-analysis resulted in a summary relative risk (RR) for NHL of 0.93 (95% confidence interval 0.83–
1.04). The cumulative meta-analysis suggests that higher RRs were detected in studies published before 1986, while
studies available after 1986 did not show an association. No differences were found between different levels of
occupational exposure.
Conclusions Notwithstanding some limitations, the results of this meta-analysis do not support the hypothesis of an
association between occupational exposure to formaldehyde and risk of NHL.
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Background
Formaldehyde is a high-volume industrial chemical with
5 million tons produced annually in the United States
(US). Major occupational sources of exposure include
manufacturing of resins for wood products, furniture
and fixtures, wearing apparel and textiles, chemicals and
plastic products;
occupational exposure to formalin, a solution of for-
maldehyde in water, occurs in several service industries,
including medical, dental and veterinary [1–3].
Exogenous formaldehyde is rapidly metabolized at the
site of entry (typically the upper respiratory tract). For-
maldehyde is also produced endogenously and is an
essential intermediate in the biosynthesis of purines,
thymidine, and various amino acids [4].
Exposure to relatively high concentrations (i.e., long-
term exposure to concentrations greater than about 4
ppm) formaldehyde has been shown to cause nasal can-
cer in animal experiments [5, 6], and associations have
been reported between occupational exposure to formal-
dehyde and risk of several types of cancer [7–9].
Human cancer risks associated with formaldehyde
exposure have been investigated in occupational co-
horts and community-based case–control studies.
Occupational cohort studies generally provide higher-
quality evidence than population-based case–control
studies, primarily due to better exposure data and a
greater potential for higher and more sustained levels
of exposure [10].
In 2006 the International Agency for Research on
Cancer (IARC) concluded that there was sufficient
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evidence in humans for the carcinogenicity of formalde-
hyde, based on results of epidemiological studies report-
ing an association with nasopharyngeal cancer; at that
time, IARC also concluded that there was “strong but
not sufficient evidence for a causal association between
leukaemia and occupational exposure to formaldehyde”
[2]. In 2009, IARC added leukaemia to the list of neo-
plasms caused by formaldehyde, although this was deter-
mined by a small majority of the Working Group [11].
Subsequently, the National Toxicology Program of the
National Institute of Environmental Health Sciences
changed the classification of formaldehyde from “antici-
pated to be carcinogenic in humans” to “known to be a
human carcinogen” [3].
Numerous reviews and meta-analyses have focused on
associations between formaldehyde and lymphohemato-
poietic cancer in general or leukemia [10, 12, 13], but no
similar review and meta-analysis has been published on
epidemiological studies evaluating exposure to formalde-
hyde and risk of non-Hodgkin lymphoma (NHL).
NHL is a histologically and genetically heterogeneous
group of malignancies originating from B- and T-cell
lineages that account for 2.7% of the global cancer bur-
den, with important variations in geographic and tem-
poral patterns of incidence [14, 15]. Known causes of
NHL explain only a small proportion of cases which
occur globally; these include chemotherapy treatment or
severe immune system dysregulation, infection with
Epstein–Barr virus, hepatitis C virus, and Helicobacter
pylori, as well as autoimmunity and atopic conditions,
high BMI, and tobacco smoking in addition to family
history of lymphatic neoplasms [16].
We therefore conducted a systematic review and
meta-analysis of epidemiological studies published inves-
tigating the association between occupational exposure
to formaldehyde and risk of NHL. We excluded studies
based on either environmental or dietary exposure to
formaldehyde because of lower and less precisely defined
exposure levels compared to workplace exposure.
Methods
The systematic review and meta-analysis were per-
formed according to the guidelines specified in the
PRISMA-statement [17]. The methods were documented
in a protocol (available upon request); the PRISMA
checklist is included in Additional file 1: Table S1.
Literature search and study selection
We conducted comprehensive literature searches of
Scopus and PubMed, up to 12 July 2018; PubMed “re-
lated article” links and reference lists of key studies and
reviews were used to complement the primary searches.
The searches included the keywords (“formaldehyde”)
AND (“cancer” OR “neoplasm” OR “lymphoma” OR
“non-Hodgkin lymphoma”).
To be included in the meta-analysis, studies had to ful-
fill the following criteria: (i) original reports based on
workers exposed to formaldehyde; (ii) studies in which
the results were reported for NHL ([ICD-9 codes 200,
202]: lymphosarcoma and reticulosarcoma and other
specified malignant tumors of lymphatic tissue; other
malignant neoplasms of lymphoid and histiocytic tissue
and [ICD-10 codes C82, C85]: follicular lymphoma;
other specified and unspecified types of non-Hodgkin
lymphoma), alone or with other categories of lymphohe-
matopoietic neoplasms (e.g., Hodgkin lymphoma [ICD-9
code 201] or multiple myeloma [ICD-9 code 203]),
excluding leukemia; (iii) studies in which a measure of
association between formaldehyde exposure and risk of
NHL, expressed either as standardized mortality ratios
(SMR), standardized incidence ratios (SIR), proportion-
ate mortality ratio (PMR), relative risk (RR) or odds ratio
(OR) either was reported or could be derived from the
publication.
Two authors (SC, FD) independently reviewed the list
of titles and abstracts, to determine which studies poten-
tially met the inclusion criteria. Duplicates and irrelevant
references were eliminated. The final selection was based
on the examination of the full text of potentially relevant
articles. Cases of disagreement or doubt were resolved
with the inclusion of a third author (PB). The search and
selection process are shown in Fig. 1.
After reviewing the titles of 3008 articles, we elimi-
nated 2905 that did not appear to be relevant, and
reviewed the abstracts of the remaining 103 articles.
Review of these led to the elimination of 53 articles
that did not meet the inclusion criteria, leaving 50 ar-
ticles for detailed review. Thirty of the 50 articles
subsequently were eliminated because exposure was
not clearly defined, or results were reported for all
lymphohematopoietic neoplasms combined ([ICD9-
codes 200–209] malignant neoplasm of lymphatic and
hematopoietic tissue). Among the remaining 20 arti-
cles, some referred to the same study population; in
such cases, we selected the report with the most
complete information (i.e., longest follow-up), leaving
for the meta-analysis 12 reports of studies of non-
overlapping populations (Table 1) [18–29].
Five of these 12 reports [29–33] were based on a single
large cohort study of workers from 10 US plants produ-
cing or using formaldehyde. This study was initiated by
the US National Cancer Institute (NCI) in the early
1980s in collaboration with the Formaldehyde Institute,
and the first results were published in 1986 [30]. We in-
cluded in the meta-analysis the results of the most re-
cent analysis of this cohort [29]. Similarly, we selected
the article by Pinkerton and coworkers (2004) [25], the
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most recent of three analyses of a cohort of workers
from three garment manufacturing facilities, located in
Georgia and Pennsylvania, USA [25, 34, 35], and the art-
icle by Coggon and colleagues (2014) [28], the most re-
cent of three articles based on a cohort of workers from
six chemical factories in England and Wales [28, 36, 37].
Data extraction
We extracted key characteristics of each of the studies
retained for the meta-analysis (Table 1). We aimed at
investigating NHL (i.e., International Classification of
Diseases, version 9 (ICD-9) codes 200, 202 and ICD-10
codes C82, C85); however, results from some studies
were available only for different disease categories (see
Table 1 for details). When results were reported based
on different strategies for adjustment for potential con-
founders, we included the fully adjusted risk estimates.
When the data were reported for different levels of ex-
posure, we chose the category at highest exposure.
Data analysis
We evaluated inter-study heterogeneity using the general
variance-based method, and applied a random effects
model which incorporates between-study variation into
the summary variance estimate to estimate summary RR
and 95% confidence interval (CI) estimates [38].
We conducted sensitivity analyses excluding one study
at a time from the meta-analysis, and a cumulative
meta-analysis according to the year of publication of the
individual studies. Finally, we conducted a meta-analysis
according to the type of average exposure level of the
workers included in each study, categorized as very low,
low and medium-high exposure.
The exposure in each study was classified as very
low when the levels of formaldehyde was estimated
lower than 10 μg/m3, low when it was between 10
and 200 μg/m3 and medium-high when it was higher
than 100 μg/m3.
The classification was made on the basis of the data
on exposure levels available from the studies included in
the meta-analysis and on the type of industry; it does
not aim to be comprehensive, such as the one proposed
by IARC [2].
We generated funnel plots of the results included in
the meta-analysis and used the test proposed by Egger
et al. [39] to assess possible publication bias.
Fig. 1 Flow chart of search and selection of studies included in the review and meta-analysis
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Results
The meta-analysis comprised results from 12 independ-
ent studies [18–29], only the study by Hansen et al. [22]
analyzed the incidence of NHL, while the remaining
studies were based on mortality data. Overall, these
studies included a total of 318 NHL cases or deaths.
Risk estimates for NHL (ICD-9200,202) were reported
in 7 studies [21–24, 26, 28, 29]; in 5 additional studies
[18–20, 25, 27] we combined, using a fixed-effect model,
the results calculated for different ICD-9 categories, as
shown in Table 1.
The results of the individual studies are reported in
Fig. 2, together with the results of the main meta-
analysis, that yielded a summary RR of 0.93 (95% CI
0.83–1.04). There was no evidence of heterogeneity
between studies (p = 0.88). The only study examining in-
cident cases of NHL reported an SIR of 0.90 (0.60–1.20),
nearly identical to the summary RR [22].
The NCI cohort [29] contributed 41.93% of the total
weight of the meta-analysis, while each of the other
studies contributed less than 13% of the total weight.
The exclusion of the NCI cohort resulted in a meta-RR
equal to 1.01 (0.95 CI 0.87–1.15). The exclusion of each
of the other studies one at a time had a lesser effect,
resulting in meta-RRs ranging from 0.91 to 0.94.
We conducted a further analysis of studies based on out-
come definition restricted to ICD-9 codes 200,202, that re-
sulted in a meta-RR of 0.92 (95% CI, 0.80–1.03) while the
meta-RR based on the other five study with mixed definitions
of outcome was 1.01 (95% CI 0.75–1.27) [ 21–24, 26, 28–29].
Table 1 Selected characteristics of studies included in the meta-analysis
Reference Country Study
design
Study
period*
Population Levels of
Exposure
Outcome I/
M
Obs/Exp N** % men
Walrath et al.,
1983 [18]
USA, New
York
Co 1902–1980 /
1925–1980
(death)
Embalmers 0.20 to 0.91 ppm ICD-8200;
202,203
M 11/9.6 n.a. 100
Walrath et al.,
1984 [19]
USA,
California
Co 1916–1978/
1925–80
(death)
Embalmers 0.2 and 0.9 ppm ICD-8200;
202,203
208 209
M 7/6.1 n.a. 100
Stroup et al.,
1986 [20]
USA Co 1888–1969 Anatomist cumulative
exposure
ICD-8200;
202, 203,
208–209
M 8/5.9 2% + 3%
migrated
100
Partanen et al.,
1993 [21]
Finland case-referent
nested
1957–1982 Wood Industry reconstructed
using a plant/
period-specific
job exposure
ICD-7200,
202
M 4/n.a. n.a.
Hansen et al.,
1995 [22]
Denmark record
linkage
1970–1984 Facilities that used
or manufactured
> 1 kg per year of
formaldehyde
Job title in
formaldeide
associated
facilities
ICD-7200,
202
I 32/37.5
Stellman et al.,
1998 [23]
USA Co 1982--f.up
1988
Wood Dust
Exposure
check.off list ICD-9200,
202
M 11/n.a. 2% 100
Band et al.,
1997 [24]
Canada Co 1950–1992 pulp and paper
mill
– ICD-9200, 202 M 35/n.a. 10% 100
Pinkerton et al.,
2004 [25]
USA Co 1955-f.up
1998
3 garment
industries
personnel
records of
exposure
ICD-9200;
202,203
M 33/n.a. n.a 18.3
Meyers et al.,
2013 [26]
USA Co 1955/59–
2008
formaldehyde
resins
campaign of
personal sampling
ICD-10
(C46.3,C82-C85,
C88.0,C88.3,
C91.4,C96)
M 66/n.a 1.1 18
Pira et al.,
2014 [27]
Italy Co 1930–1966 or
1934–58 until
2004
laminated plastic
workers
time of
employment
ICD-9200–202 M 4/5.4 3.1 81
Coggon et al.,
2014 [28]
UK Co 1941–2012 chemical workers recorded titles
of jobs
ICD-9200,202 M 13/14.4 100
Checkoway
et al., 2015
[29]
USA Co 1930–1966 or
1934–58 until
2004
manufacturersor
users of
formaldehyde,
estimated for
each job from
individual work
histories
ICD-8200,202 M 94/n.a. 81.8
NR not relevant, NA not available, Co cohort study, CC case-control study, NCC case-control study nested in a cohort, I incidence, M mortality, N number of cohort
members (cohort studies) or number of cases (case-control studies), NHL non-Hodgkin lymphoma, ICD International Classification of Diseases
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The cumulative meta-analysis suggests that slightly
higher RRs (all with RR ≤ 1.16 and none statistically sig-
nificantly elevated) were detected based on the three
earliest studies (published before 1986), while the meta-
RR of studies available after 1986 ranged from 0.85 to
0.95 without a clear trend during this period (Fig. 3).
In the analysis according to level of exposure made on
the basis of the data on exposure levels available from
the studies included in the meta-analysis and on the type
of industry, we classified as “very low” exposure the
studies conducted in laminated plastic manufacturing,
where formaldehyde is a by-product released from resins
in the phase of machining [27], in pulp and paper mills
[24] and in 265 Danish companies in which more than
1 kg of formaldehyde was used or manufactured per em-
ployee per year [22]. The meta-RR of these studies with
very low exposure was 0.97 (95% CI 0.76–1.18).
Exposure was classified as “low” in studies conducted
in the wood industry [21, 23] and in garment
manufacturing facilities [26, 27]. The meta-RR of these
studies was 1.02 (95% CI 0.80–1.24). Finally, the expos-
ure was classified as “medium-high” in studies con-
ducted among embalmers and anatomists [18–20], in 10
US plants producing or using formaldehyde [ 29](manu-
facture of formaldehyde, formaldehyde-based resins, or
molding compounds, or use of formaldehyde-based
resins or molding compounds, including molded plastic
products, decorative laminates, photographic film, and
plywood) and in six British chemical factories at a time
when formaldehyde was produced or used [28]. The
meta-RR of these studies was 0.87 (95% CI 0.72–1.02).
There was no evidence of heterogeneity between the
three groups of studies (p-heterogeneity between sum-
mary risk estimates 0.43).
The visual assessment of the funnel plot (Fig. 4) and
the result of the Egger’s test (P = 0.056) suggested the
possibility of publication bias, with negative results of
small studies apparently being missing.
Fig. 2 Forest plot of results of studies included in the meta-analysis. RR and 95% CIs of NHL cancer associated with Formaldehyde exposure.
Horizontal lines represent 95% CIs for the study-specific RRs. The sizes of the dots for the individual studies are proportional to the study weight.
The pooled RR, which was shown as a diamond, was 0.93 (0.83, 1.04). The middle of the diamond corresponds to the RR, and the width of the
diamond represents the 95% CI. The arrows indicate greater or lesser confidence intervals with respect to the reported scale
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Some studies carried out an assessment of the risk of
NHL in relation to time-related indicators of exposure
(Additional file 1: Table S2).
Results by duration of exposure were reported in a few
studies. In the US garment workers’ study [26], the SMR
for NHL for exposure > 10 years was 1.21 (95% CI 0.69–
1.97), while in one the analyses of the NCI study [32] the
RR for > 15 years of exposure was 0.98 (95% CI 0.49–1.96)
and in the study of laminated plastic workers from Italy
[26] the SMR for > 20 years of exposure was 0.76.
Four studies reported results by time of first formalde-
hyde exposure [26, 27, 35, 37]. In the study of US gar-
ment workers [26], the SMR for workers first employed
before 1963 was 1.19 (95% CI 0.82–1.69), for workers
first employed between 1963 and 1971 the SMR was
1.11 (95% CI 0.53–2.04) and for workers first employed
after 1971 the SMR was 0.65 (95% CI 0.08–2.33) (26). In
a subsequent analysis of this study [34], the SMR for
other lymphatic and hematopoietic neoplasms, including
NHL, was highest (SMR 1.64; 95% CI not available)
among workers first exposed during 1955–1962, when
potential formaldehyde exposure was highest. In the
study of Italian laminated plastic workers [27] there was
no trend by period of first employment. In the study of
UK chemical workers [37], mortality for NHL was higher
in worker employed after 1964 than in workers
employed before that.
Analyses by cumulative exposure to formaldehyde were
reported in several articles based on the NCI cohort study
[30, 32, 33]. In particular, the RR for cumulative exposure
above 5.5 ppm-years was 0.91 (95% CI 0.54–1.52), with no
trend (p > 0.5) [33]. Analyses according to peak exposure in
the same cohort also failed to detect a dose-response rela-
tionship with risk of NHL [32, 33].
Discussion
Our meta-analysis of studies of individuals exposed to
formaldehyde provided no evidence of an increased risk
of NHL overall (RR 0.93; 95% CI 0.83–1.04) or by
Fig. 3 Cumulative meta-analysis according to the year of publication
of the individual studies. The circles represent the RRs of the studies
conducted in different years, the lines are the respective 95% CIs
Fig. 4 Funnel plot of studies included in the meta-analysis. Each dot represents a study; the y-axis represents study precision and the x-axis
shows the study’s result
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various exposure categories or characteristics. The meta-
analysis comprised results from 11 independent studies
with data of mortality of NHL and one that analyzed the
incidence of NHL. Study populations were employed in
laminated plastic manufacture, in pulp and paper mills,
in the wood industry, in garment manufacturing facil-
ities, among embalmers and anatomists and different
plants producing or using formaldehyde; no differences
of risk were found in different types of exposure. The
limited data on time-related indicators of exposure did
not find any trend indicating an increased risk of mortal-
ity for NHL with longer duration of exposure, longer
‘time since first exposure” or higher exposure level.
Because of its high water solubility and reactivity, for-
maldehyde is expected to exert its toxicity predomin-
antly at the site of entry. As a result of its reactivity in
target tissues, formaldehyde causes local irritation, acute
and chronic toxicity and has genotoxic and cytotoxic
properties [40].
Genotoxicity may play an important role in the
carcinogenicity of formaldehyde in nasal tissues in
humans, in addition, cellular replication in response to
formaldehyde-induced cytotoxicity may promote the
carcinogenic response [41]. There is controversy on the
ability of formaldehyde to cause leukemia [42]. Three
mechanisms were suggested by which formaldehyde
could act as a leukemogenic: (i) by damaging stem cells
in the bone marrow directly (ii) by damaging haemato-
poietic stem/progenitor cells circulating in the peripheral
blood, and (iii) by damaging the primitive pluripotent
stem cells present within the nasal turbinates or olfac-
tory mucosa [13, 43–45].
NHL include a diverse group of neoplasms derived
from T- and B-cells and their precursors in the lymph-
oid system; a genotoxic action on circulating stem cells
would be consistent with the possibility that formalde-
hyde is a cause of lymphatic neoplasms, and one would
expect that the mucosa-associated lymphatic tissue in
the nasal region would be particularly at risk. There is
also recognition of their inter-relatedness of these neo-
plasms through a common stem cell, and the malignant
transformation might take place during various stages of
the differentiation and maturation process of the precur-
sor cells in bone marrow [46]. Evidence suggests that an
underlying cytogenetic abnormality in an early precursor
cell predisposes to subsequent mutations leading to a
specific lymphohematopoietic neoplasm [47]. Assuming
that the leukemogenic mechanisms mentioned above
have a biologic plausibility, the possibility of a mutagenic
effect of formaldehyde on circulating lymphocytes or
local lymphatic tissue could not be ruled out; however,
evidence on how this might occur currently is lacking.
Based on these hypothesis we decided to conduct a re-
view of the relevant epidemiological studies investigating
the relationship between occupational formaldehyde ex-
posure and risk of NHL, but we found no evidence of an
increased risk of this group of neoplasms in diverse
groups of workers exposed to formaldehyde.
The main strengths of our study were the exhaustive
nature of the literature search, and the focus on results
with a specific definition of the phenotype that led to
the exclusion of the studies that analyzed all lymphohe-
matopoietic neoplasms (ICD 200–209), or other combi-
nations including leukemia.
Limitations of our review reflect those of the available
studies. They include the lack of quantitative assessment
of exposure in most studies and the heterogeneity of the
occupational exposure circumstances. We aimed at
addressing the latter issue by categorizing the studies
according to level of exposure, and found no difference
between the groups. The cumulative meta-analysis sug-
gests a weakly higher RR in the first three studies com-
pared to more recent studies. Explanations for this
pattern might include a higher intensity of exposure to
formaldehyde (which assumes a causal relationship that
is not apparent) or more likely by a greater opportunity
for bias in the earliest studies. The analysis of publica-
tion bias further supports the conclusion of no associ-
ation between formaldehyde exposure and risk of NHL.
Additional evidence is provided by a large, case-
control study that was conducted in Montreal,
Canada, during 1979–1985 [48]. This study included
3723 male cases of multiple types of cancer, including
215 cases of NHL, who were compared to 2357 cases
of other cancers, and to 533 population controls.
Based on detailed occupational interviews, a team of
experts assessed exposure to 294 agents, including
formaldehyde, by examining each work history and
rating each job on a 3-point scale with regard to their
confidence that exposure had actually occurred, the
frequency of exposure, and the relative concentration
level. Exposure was defined as ‘substantial’ when it
lasted for more than 5 years at medium or higher
level of frequency and concentration, and with prob-
able or definite confidence by the experts. The preva-
lence of ever-exposure to formaldehyde was 15%;
main occupations that included exposed subjects were
carpenters and textile workers. The results were ad-
justed for age, ethnicity, socioeconomic status, and
self/proxy status of the respondent. The OR of NHL
for ever-exposure to formaldehyde was 0.8 (95% CI,
derived from data reported in the publication, 0.6–
1.2; 28 exposed cases); that for ‘substantial’ exposure
was 1.2 (95% CI, derived from data reported in the
publication, 0.5–2.7; 6 cases). These results were not
included in the meta-analysis because the study did
not meet the inclusion criteria; however, they are
consistent with those of the meta-analysis in showing
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that formaldehyde exposure is not associated with in-
creased risk of NHL.
Conclusion
In conclusion, we found no indication of any association
between various indicators of occupational exposure to
formaldehyde and risk of NHL.
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